An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer

BMC Medical Genomics

Table 1 Summary of lung cancer datasets used in this study.

Database	GEO	Platform	Institute	PMID	Technology type	Organism	AD#	SCC#	Stage	# Genes	% Correct AD	% Correct SCC
1	GSE3398	GPL2648/2778/2832	Stanford	11707590	spotted cDNA	Human	41	17	I to III	17	93	94
2	NA*	Affy HG-U95A	DFCI	11707567	oligonucleotide	Human	139	21	I to III	17	91	86
3	NA**	Affy HG-U133A	U Michigan	12118244	oligonucleotide	Human	86	0	I to III	17	95	NA
4	GSE3141	Affy U95A/HuGeneFL	Duke	16899777	oligonucleotide	Human	54	57	I to III	17	83	72
5	GSE4573	Affy HG-U133A	U Michigan	16885343	oligonucleotide	Human	0	129	I to III	17	NA	85
6	GSE1037	CHUGAI 41K	CIH, Japan	15016488	spotted cDNA	Human	12	0	NA	17	83	NA
7	GSE6253	Affy HG-U95A/U133AB	Washington U	17194181	oligonucleotide	Human	14	36	I	17	79	78
8	GSE3268	Affy HG-U133A	UC Davis	16188928	oligonucleotide	Human	0	5	NA	17	NA	100
9	GSE1987	Affy HG-U95A	Tel Aviv U	NA	oligonucleotide	Human	8	17	I to III	17	88	59
10	GSE6044	Affy HG-Focus	U Duesseldorf, Germany	NA	oligonucleotide	Human	10	10	NA	16	70	90
11	GSE7880	Affy HG-Focus	Heinrich-Heine U, Germany	NA	oligonucleotide	Human	25	18	IIIB/IV	16	92	83
12	GSE2514	Affy HG-U95A	U Colorado	16314486	oligonucleotide	Human	20	0	NA	15	100	NA
13	GSE5843 GSE5123	PC Human Operon v2	Prince Charles H, Australia	17082175 17504995	oligonucleotide	Human	48	51	I to III	14	75	80
14	GSE2514	Affy MG-U74A	U Colorado	16314486	oligonucleotide	Mouse	44	0	NA	13	100	NA

ISSN: 1755-8794